Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03970317 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Broad Band Light In Motion Treatment

A NA study, sponsored by Sciton.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT03970317: Completed NA study, sponsored by Sciton.

NCT03970317 is a NA study that has completed, run by Sciton. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03970317, a NA study, has completed, sponsored by Sciton.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

Evaluate safety and efficacy of Broad Band Light (BBL) motion technique treatment for pigmentation, skin tone and texture

Primary Outcome

Evaluation of Photographs using Physician's Global Assessment Scale (0-4) where 0 is no change and 4 is very significant improvement

Interventions

  • DEVICE Broad Band Light

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2019-04-12
Est. Completion 2020-09-29
Phase NA
Sciton

12 total trials

What the finished NCT03970317 record still lists

NCT03970317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Broad Band Light is the first listed.

NCT03970317 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03970317 about?

NCT03970317 is a clinical study titled "Safety and Efficacy of Broad Band Light In Motion Treatment". Evaluate safety and efficacy of Broad Band Light (BBL) motion technique treatment for pigmentation, skin tone and texture

What is the current status of trial NCT03970317?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2019-04-12. Estimated completion is 2020-09-29.

What interventions are being tested in trial NCT03970317?

The interventions under investigation include: Broad Band Light (DEVICE).

Who is sponsoring clinical trial NCT03970317?

This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03970317's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03970317, the US trial registry maintained by the National Library of Medicine. NCT03970317 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.